» Articles » PMID: 28516270

[Ocular Sarcoidosis]

Overview
Journal Z Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2017 May 19
PMID 28516270
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Ocular manifestation of sarcoidosis occurs in up to 60% of patients with confirmed systemic sarcoidosis and represents one of the most common forms of noninfectious uveitis. In known pulmonary sarcoidosis, ocular involvement can occur in up to 80% of cases. Sarcoidosis can also present only in the eye, without a systemic manifestation (ocular sarcoidosis). Typically, ocular sarcoidosis shows bilateral granulomatous uveitis and can involve all parts of the eye. Apart from an acute anterior uveitis, chronic intermediate or posterior uveitis can be found. In order to prevent a severe reduction of visual acuity leading to blindness, early diagnosis and treatment is essential. For diagnosis, specific clinical signs involving the eye (bilateral granulomatous changes in all parts of the eye) and typical laboratory investigations (angiotensin-converting enzyme, ACE; lysozyme; soluble interleukin 2 receptor, sIL2R; chest X‑ray; chest CT) have to be taken into account, since biopsy to prove noncaseating granulomas is not performed with changes restricted to the eye due to the high risk of vision loss. Ocular sarcoidosis mostly responds well to local or systemic steroid treatment. If the therapeutic effect is insufficient, immunosuppressive agents and biologics can be applied.

Citing Articles

Diagnosis of systemic sarcoidosis in a patient with bilateral granulomatous pan-uveitis: a case report.

Thapaliya S, Pant P, Paudel S, Ghimire S Ann Med Surg (Lond). 2024; 86(1):607-611.

PMID: 38222700 PMC: 10783219. DOI: 10.1097/MS9.0000000000001606.


Performance of Serum Angiotensin-Converting Enzyme in Diagnosing Sarcoidosis and Predicting the Active Status of Sarcoidosis: A Meta-Analysis.

Hu X, Zou L, Wang S, Zeng T, Li P, Shen Y Biomolecules. 2022; 12(10).

PMID: 36291609 PMC: 9599650. DOI: 10.3390/biom12101400.


[Association of the different forms of uveitis with inflammatory rheumatic diseases and their treatment].

Stubiger N, Farrokhi S, Gkanatsas Y, Deuter C, Kotter I Z Rheumatol. 2022; 81(8):667-681.

PMID: 36040536 DOI: 10.1007/s00393-022-01244-y.


Delayed Diagnosis in a Rare Case of Pulmonary Sarcoidosis Presenting as Unilateral Hilar Lymphadenopathy and Fever of Unknown Origin.

Thomas P, Mabrouk T, Li Y, Wallach S Cureus. 2021; 13(6):e15792.

PMID: 34295598 PMC: 8293858. DOI: 10.7759/cureus.15792.

References
1.
Beegle S, Barba K, Gobunsuy R, Judson M . Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Des Devel Ther. 2013; 7:325-38. PMC: 3627473. DOI: 10.2147/DDDT.S31064. View

2.
Bonfioli A, Orefice F . Sarcoidosis. Semin Ophthalmol. 2005; 20(3):177-82. DOI: 10.1080/08820530500231938. View

3.
Chung Y, Lin Y, Huang D, Hwang D, Ho D . Conjunctival biopsy in sarcoidosis. J Chin Med Assoc. 2006; 69(10):472-7. DOI: 10.1016/S1726-4901(09)70311-9. View

4.
Deverriere G, Flamans-Klein A, Firmin D, Azouzi O, Courville P, le Roux P . [Early onset pediatric sarcoidosis, diagnostic problems]. Arch Pediatr. 2012; 19(7):707-10. DOI: 10.1016/j.arcped.2012.04.024. View

5.
Erckens R, Mostard R, Wijnen P, Schouten J, Drent M . Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol. 2011; 250(5):713-20. PMC: 3332360. DOI: 10.1007/s00417-011-1844-0. View